Japanese Researchers Discover Drug Target For Osteoporosis, Rheumatoid Arthritis
This article was originally published in PharmAsia News
Executive Summary
A team led by osteo-immunology professor, Hiroshi Takayanagi, of Tokyo Medical and Dental University, found two enzymes in osteoclastic cells that cause osteoporosis and rheumatoid arthritis. If inhibitors inside the human body can be developed to constrain the enzymes, the research could lead to the discovery of treatments for the diseases. By analyzing DNA of the cells, the team found that the enzyme Btk and Tec are responsible for building the cells. After compounds that constrain the two enzymes were given to a mouse, symptoms of osteoporosis and rheumatoid arthritis improved. (Click here for more - Japanese language